Streamline Health merger converts shares to $5.34; warrants canceled for no consideration
Rhea-AI Filing Summary
Matthew Etheridge, a director of Streamline Health Solutions, reported dispositions tied to a merger that took effect on 08/12/2025. Under the Merger Agreement dated May 29, 2025, the company became a wholly owned subsidiary of Mist Holding Co., and each outstanding share of Streamline common stock was canceled and converted into the right to receive $5.34 in cash per share. The filing notes numbers were adjusted for a 1-for-15 reverse stock split effected on October 4, 2024.
The Form 4 shows Mr. Etheridge disposed of 30,876 common shares resulting in 0 common shares beneficially owned following the transaction. It also reports 61,403 underlying shares from Company warrants (exercise price listed as $5.85) that were canceled; warrants with exercise prices equal to or above the merger consideration were canceled for no consideration.
Positive
- Merger consideration of $5.34 per common share provides a cash exit for shareholders
- Transaction effective date (08/12/2025) and reporting show the merger and conversion were completed
Negative
- 61,403 warrant-based shares were canceled; warrants with a $5.85 exercise price were canceled for no consideration
- Reporting person’s beneficial ownership of common stock and warrants is shown as 0 following the transaction, indicating loss of ongoing equity stake
Insights
TL;DR: Form 4 documents a merger closing that converted common shares to $5.34 cash and canceled certain warrants.
The filing confirms the Merger Agreement became effective on 08/12/2025, converting each outstanding share into $5.34 cash and extinguishing public equity. The reported figures — 30,876 common shares disposed and 61,403 warrant-related underlying shares canceled — reflect the post-1-for-15 reverse-split adjusted counts. For holders, common shares received cash consideration while warrants with an exercise price at or above $5.34 were canceled for no consideration, per the agreement. This is a material corporate action that finalizes consideration to holders and ends their equity exposure.
TL;DR: Insider Form 4 confirms corporate control change and extinguishment of public equity and certain derivative claims.
The Form 4 provides clear documentation that Streamline Health became a wholly owned subsidiary of the acquirer at the Effective Time, with outstanding common shares canceled for $5.34 per share and certain warrants canceled without payment where the exercise price met or exceeded the merger consideration. The reporting director's beneficial ownership is reduced to zero for both common stock and warrants, evidencing completion of the transaction and transfer of economic rights to the merger consideration. This filing is a definitive, material disclosure about corporate control and investor pay-out mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Warrant (right to buy) | 61,403 | $0.00 | -- |
| Disposition | Common Stock, $0.01 par value | 30,876 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration"). The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split. Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration.
